BIOLASE Inc (BIOL) Stock
BIOL is no longer traded. BIOLASE was delisted from the Nasdaq in October 2024.
Prices on this page are historical; the last trade was October 3, 2024 at $0.02.
BIOLASE stock price history
BIOL final trading statistics
- Final close
- $0.02
- Final trading day
- Oct 3, 2024
- Market cap at delisting
- $567.3K
- Shares outstanding
- 36.60M
- Final 52-week range
- $0.01 – $1.94
- Avg. volume (final 3 mo.)
- 446,861
- All-time high (split-adj.)
- $242657.41 · Jan 2004
- All-time low (split-adj.)
- $0.01 · Sep 2024
- Return since IPO
- -100.0%
- Beta
- 0.68
- Book value / share
- -$0.13
- Price / book
- -0.12
BIOLASE annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $49.16M | -$20.6M | -$14.07 |
| FY2022 | $48.46M | -$28.6M | -$4.10 |
| FY2021 | $39.19M | -$16.2M | -$3.25 |
| FY2020 | $22.78M | -$16.8M | -$8.75 |
| FY2019 | $37.80M | -$17.9M | -$11.25 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About BIOLASE Inc
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. On October 1, 2024, BIOLASE, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
BIOLASE stock FAQ
What happened to BIOLASE stock?
BIOLASE stock was delisted from the Nasdaq. Its final close was $0.02 on October 3, 2024.
Is BIOL stock still trading?
No. BIOL was delisted from the Nasdaq in October 2024 and no longer trades on a U.S. exchange.
What was the last price of BIOL stock?
BIOL closed at $0.02 on its final trading day, October 3, 2024, for a market value of about $567.3K.
What were BIOLASE's revenue and earnings in its last full fiscal year?
BIOLASE reported revenue of $49.16M and net income of -$20.6M in fiscal 2023, its last full year as a public company.
When did BIOLASE go public?
BIOLASE Inc stock began trading on November 13, 1992.